Publication Topic

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554; PMID: 14600248.

Warren DA, Kerger BD, Britt JK, James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005.

Panko JM, Unice KM, Shay EC, Price P. Childhood exposure assessment of acetone. International Society for Exposure Assessment, 2004.

Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ III. 2004. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A 67:43–71.

Proctor DM, Panko JM, Liebig EW, Paustenbach DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. J Occup Environ Hyg 1(11):752–767; doi: 10.1080/15459620490523294.

Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H., et al. 2004. Ochratoxin A: Lack of formation of covalent DNA adducts. Chem Res Toxicol 17(2):234–242; doi: 10.1021/tx034188m. PMID: 14967011.

Rogers JM, Brannen KC, Barbee BD, Zucker RM, Degitz SJ. 2004. Maternal methanol exposure during gastrulation causes holoprosencephaly, facial dysgenesis and cervical vertebral malformations in C57BL/6J mice. Birth Defects Res B 71(2):80-88; doi: 10.1002/bdrb.20003.

Degitz SJ, Rogers JM, Zucker RM, Hunter ES III. 2004. Developmental toxicity of methanol: Pathogenesis in CD-1 and C57BL/6J mice exposed in whole embryo culture. Birth Defects Res A 70(4):179–184; doi: 10.1002/bdra.20009.

Degitz SJ, Zucker RM, Kawanishi CY, Massenburg GS, Rogers JM. 2004. Pathogenesis of methanol-induced craniofacial defects in C57BL/6J mice. Birth Defects Res A 70(4):172–178; doi: 10.1002/bdra.20010.

Slikker W Jr., Andersen ME, Bogdanffy MS, Bus JS, Cohen SD, Conolly RB, David RM, Doerrer NG, Dorman DC, Gaylor DW, Hattis D, Rogers JM, Setzer RW, Swenberg JA, Wallace K. 2004. Dose-dependent transitions in mechanisms of toxicity. Toxicol Appl Pharmacol 201(3):203–225; doi:10.1016/j.taap.2004.06.019.

Clewell HJ, Gentry PR, Covington TR, Sarangapani R, Teeguarden JG. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol Sci 79(2):381–93.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Disposition of 2,2’,4,4’-tetrabromodiphenylether (BDE 47) in female mice. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Lau C, JL Butenhoff, JM Rogers. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241; doi: 10.1016/j.taap.2003.11.031.

Hardick J, Gaydos CA, Wagner M, Hardick A, Wood BJ, Miller M. High prevalence of trichomonas vaginalis among women who use drugs in New York City. National STD Prevention Conference, Philadelphia, PA, 2004.

Lea IA, Widgren EE, O’Rand MG. 2004. Association of sperm protein 17 with A-kinase anchoring protein 3 in flagella. Reprod Biol Endocrinol 2(Jul 16):57; doi: 10.1186/1477-7827-2-57.

Tice RR, Choksi NY, Allen DG, Haseman JH, Hill R, Lewis M, et al. Estimation of the underprediction rates for the in vivo rabbit dermal corrosion assay. Poster presented at Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Choksi NY, Haseman JH, Allen DG, Tice RR, Stokes WS. Estimation of the underprediction rates for the in vivo rabbit dermal irritation assay. Poster presented at Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Jahnke GD, Choksi NY, Moore JA, Shelby MD. 2004. Thyroid toxicants: Assessing reproductive health effects. Environ Health Perspect 112(3):363–368; doi: 10.1289/ehp.6637.

Urban JD, Gay EA, Mailman RB. Decreased neurological side-effects with aripiprazole: A result of functional selectivity of the D2 receptor? Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect 112(1):9-17; doi: 10.1289/ehp.6559.